+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-09-29Number of Pages: 170

High Throughput Process Development Market (Product and Service - Instruments, Software and Services, Consumables and Reagents; End User - Biopharmaceutical Manufacturers and Contract Manufacturers; Molecule Type - Monoclonal Antibodies, Vaccines, Recombinant Insulin, and Human Growth Hormones; Process Type - Downstream Processing and Upstream Processing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022

Global High Throughput Process Development Market: Snapshot

The escalating pressure to decrease the manufacturing cost and the rising growth of the biopharmaceutical sector is influencing the high throughput process development market substantially across the world. Since high throughput process development addresses the concerns regarding the reduction of development time and the designing of strong and scalable processes by enhancing process knowledge, its adoption rate has increased remarkably, worldwide. The usefulness of high throughout tools in performing parallel screening of chromatography issues and media while saving enough time for process developers is also boosting this market considerably.

The global market for high throughput process development is expected to touch US$10.59 bn by 2017. The market’s opportunity will further expand at an impressive CAGR of 11.60% over the period from 2017 to 2022, increasing to US$18.35 bn by the end of 2022. The augmenting application of high throughput process development in membrane chromatography will be driving this market significantly in the years to come.

high throughput process development market

Demand for Consumables and Reagents to Remain Strong

Instruments, consumables and reagents, and software and services are the main products and services, the global high throughput process development market offers to its consumers. The demand for consumables and reagents is comparatively higher than other high throughput process development products and services and the trend is projected to continue in the near future.

High throughput process development solutions witness a significantly high demand from biopharmaceutical manufacturers and contract manufacturers. With the rising trend of outsourcing, contract manufacturers are expected to emerge as the leading end user of high throughput process development solutions over the next few years.

Monoclonal antibodies, recombinant insulin, vaccines, and human growth hormones are the main types of molecules used in high throughput process development solutions. These solutions can also be bifurcated into downstream processing and upstream processing on the basis of the type of the process of the development.

North America to Continue as Market Leader

The Middle East and Africa (MEA), Asia Pacific excluding Japan (APEJ), Latin America, North America, Europe, and Japan have surfaced as the main regional markets for high throughput process development across the world. North America has secured the leading position in the global market and is expected to retain it over the next few years. The rising demand for decreasing product development timelines, increasing need for the improvement in the manufacturing quality of biological materials, and a prominent existence of established players are expected to boost the North America market for high throughput process development in the near future.

Europe is also reporting a steady rise in its high throughput process development market, which is projected to continue over the forthcoming years. The APEJ region, however, is anticipated to pose a challenge to the leading regional markets in terms of the growth rate over the period of the forecast. The main factors behind the significant rise in the APEJ market for high throughput process development are the increasing government support for infrastructural development, expanding private-public partnerships, rising trend of outsourcing, and the augmenting expenditure on research and development activities.

Bio-Rad Laboratories Inc., Tecan Group Ltd., Eppendorf AG, Perkinelmer Inc., Thermo Fisher Scientific Inc., Danaher Corp., Sartorius Stedim Biotech, GE Healthcare, Agilent Technologies Inc., and Merck Millipore are some of the main players operational in the global high throughput process development market.

Global High Throughput Process Development Market: Overview

The rising need to reduce the manufacturing cost is having a significant impact on the global high throughput process development market. The continual growth of the biopharmaceutical industry is also boosting this market substantially. This research report presents an assessment of the global market for high throughput process development at the global as well as the regional level and make future predictions in terms of revenue (US$ Mn) and volume (Kilo Tons) during the period from 2017 to 2022.

The research report studies the drivers, restraints, challenges and opportunities in this market to determine its future status, by examines the impact of these factors on the adoption rate of high throughput process development across the world during the forecast period. The report also highlights opportunities in the high throughput process development market at the global and regional level.

The report consists of a thorough analysis of the value chain, which provides an exhaustive view of the global high throughput process development market. It also encompasses an analysis of the market’s attractiveness, in which, the end users are benchmarked on the basis of their market size, rate of the growth, and general attractiveness.

Global High Throughput Process Development Market: Segmentation

The study further presents a decisive view of the global high throughput process development market by classifying it on the basis of a number of important market parameters. Broadly, the market has been evaluated on the basis of the product and service, end user, type of the molecule, and the type of the process in the market study. Based on the product and service, the market is categorized into instruments, software and services, consumables and reagents. By the end user, the market is bifurcated into biopharmaceutical manufacturers and contract manufacturers. On the basis of the type of the molecule, the market is classified into vaccines, monoclonal antibodies, recombinant insulin, and human growth hormones. In terms of the type of process, the market is divided into downstream processing and upstream processing.

The report has also analyzed the worldwide market for high throughput process development on the basis of its regional spread. As per the study, the market is segmented into North America (the U.S. and Canada), the Middle East and Africa (South Africa, Turkey, Israel, and GCC countries), Asia Pacific excluding Japan (South Korea, China, India, Australia, Singapore, and Indonesia), Latin America (Argentina, Mexico, and Brazil), Europe (Germany, Italy, the U.K., Spain, France, and Nordic countries), and Japan.

It also offers the estimated market size of high throughput process development for 2017 and forecast till 2022. The global market size of high throughput process development has been provided in terms of revenue and kilo tons. The market numbers have been estimated based on the key segments of high throughput process development and the market size and forecast for each of the segments have been provided in terms of global and regional markets.

Companies Mentioned in the Report

The research study also includes a detailed analysis of the completive landscape prevalent in the global market for high throughput process development by reviewing the profiles of the leading market players. Bio-Rad Laboratories Inc., Tecan Group Ltd., Eppendorf AG, Perkinelmer Inc., Thermo Fisher Scientific Inc., Danaher Corp., Sartorius Stedim Biotech, GE Healthcare, Agilent Technologies Inc., and Merck Millipore are some of the main market participants mentioned in this research study.


 
 
Back To Top